[1]
Lopez-Usina, A. et al. 2024. Comprehensive Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Literature Review. Journal of Clinical Medicine Research. 16, 10 (Oct. 2024), 449–464. DOI:https://doi.org/10.14740/jocmr6033.